Literature DB >> 29791959

Sarcopenia: Beyond Muscle Atrophy and into the New Frontiers of Opportunistic Imaging, Precision Medicine, and Machine Learning.

Leon Lenchik1, Robert D Boutin2.   

Abstract

As populations continue to age worldwide, the impact of sarcopenia on public health will continue to grow. The clinically relevant and increasingly common diagnosis of sarcopenia is at the confluence of three tectonic shifts in medicine: opportunistic imaging, precision medicine, and machine learning. This review focuses on the state-of-the-art imaging of sarcopenia and provides context for such imaging by discussing the epidemiology, pathophysiology, consequences, and future directions in the field of sarcopenia. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Year:  2018        PMID: 29791959     DOI: 10.1055/s-0038-1641573

Source DB:  PubMed          Journal:  Semin Musculoskelet Radiol        ISSN: 1089-7860            Impact factor:   1.777


  19 in total

1.  Correlation between muscle mass and quality around the hip and of psoas muscles at L3 level using unenhanced CT scans.

Authors:  Stefania Zannoni; Domenico Albano; Maria Laura Jannone; Carmelo Messina; Luca Maria Sconfienza
Journal:  Skeletal Radiol       Date:  2020-05-31       Impact factor: 2.199

2.  Automated Segmentation of Tissues Using CT and MRI: A Systematic Review.

Authors:  Leon Lenchik; Laura Heacock; Ashley A Weaver; Robert D Boutin; Tessa S Cook; Jason Itri; Christopher G Filippi; Rao P Gullapalli; James Lee; Marianna Zagurovskaya; Tara Retson; Kendra Godwin; Joey Nicholson; Ponnada A Narayana
Journal:  Acad Radiol       Date:  2019-08-10       Impact factor: 3.173

Review 3.  Imaging of sarcopenia: old evidence and new insights.

Authors:  Domenico Albano; Carmelo Messina; Jacopo Vitale; Luca Maria Sconfienza
Journal:  Eur Radiol       Date:  2019-12-13       Impact factor: 5.315

4.  Automated Muscle Measurement on Chest CT Predicts All-Cause Mortality in Older Adults From the National Lung Screening Trial.

Authors:  Leon Lenchik; Ryan Barnard; Robert D Boutin; Stephen B Kritchevsky; Haiying Chen; Josh Tan; Peggy M Cawthon; Ashley A Weaver; Fang-Chi Hsu
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2021-01-18       Impact factor: 6.053

Review 5.  Opportunistic Screening for Osteoporosis Using Computed Tomography: State of the Art and Argument for Paradigm Shift.

Authors:  Leon Lenchik; Ashley A Weaver; Robert J Ward; John M Boone; Robert D Boutin
Journal:  Curr Rheumatol Rep       Date:  2018-10-13       Impact factor: 4.592

6.  Machine Learning for Automatic Paraspinous Muscle Area and Attenuation Measures on Low-Dose Chest CT Scans.

Authors:  Ryan Barnard; Josh Tan; Brandon Roller; Caroline Chiles; Ashley A Weaver; Robert D Boutin; Stephen B Kritchevsky; Leon Lenchik
Journal:  Acad Radiol       Date:  2019-07-17       Impact factor: 3.173

7.  Opportunistic Measurement of Skeletal Muscle Size and Muscle Attenuation on Computed Tomography Predicts 1-Year Mortality in Medicare Patients.

Authors:  Leon Lenchik; Kristin M Lenoir; Josh Tan; Robert D Boutin; Kathryn E Callahan; Stephen B Kritchevsky; Brian J Wells
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2019-06-18       Impact factor: 6.053

Review 8.  Total-Body PET Imaging of Musculoskeletal Disorders.

Authors:  Abhijit J Chaudhari; William Y Raynor; Ali Gholamrezanezhad; Thomas J Werner; Chamith S Rajapakse; Abass Alavi
Journal:  PET Clin       Date:  2021-01

9.  The psoas muscle density as a predictor of postoperative complications and 30-day mortality for acute mesenteric ischemia patients.

Authors:  Shou-Liang Miao; Xiao-Ning Ye; Xiang-Wu Zheng; Fan-Feng Chen; Ting-Ting Lin; Yi-Hui Qiu; Jing-Yong Huang
Journal:  Abdom Radiol (NY)       Date:  2020-09-05

10.  Sarcopenia and osteosarcopenia in seriously injured motor vehicle crash occupants.

Authors:  Ashley A Weaver; Casey Costa; Alexander Ambrosini; Josh Tan; Lisa Maez; Xin Ye; Joel D Stitzel; Leon Lenchik
Journal:  Traffic Inj Prev       Date:  2019-11-01       Impact factor: 1.491

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.